Clinical trial
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
NCT02145559 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
- Lead sponsor
- University of Chicago
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- July 31, 2018
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasms, cancer of kidney, cancer of liver, lung neoplasms, lymphoma